Oculis Holding AG SEC filings OCSAW
Oculis Holding AG has 138 filings in SEC EDGAR's recent list, going back to Nov 7, 2022. Its latest annual report, Form 20-F, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 3, 2026 | — |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | May 29, 2026 |
| 6-K | Current report (foreign issuer) | May 14, 2026 | May 14, 2026 |
| 6-K | Current report (foreign issuer) | May 11, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 4, 2026 | Mar 4, 2026 |
| F-3ASR | Filing | Mar 4, 2026 | — |
| 20-F | Annual report (foreign issuer) | Mar 4, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 3, 2026 | Mar 3, 2026 |
| EFFECT | Filing | Dec 8, 2025 | — |
| POS AM | Filing | Dec 5, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 31, 2025 | Oct 31, 2025 |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 6, 2025 | Oct 6, 2025 |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 5, 2025 | Jun 5, 2025 |
| 6-K | Current report (foreign issuer) | May 9, 2025 | May 9, 2025 |
| 6-K | Current report (foreign issuer) | May 8, 2025 | May 8, 2025 |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 20-F | Annual report (foreign issuer) | Mar 11, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 11, 2025 | Mar 11, 2025 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Feb 14, 2025 |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 6, 2025 | Jan 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 3, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Dec 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 29, 2024 | Nov 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2024 | Nov 7, 2024 |
| EFFECT | Filing | Sep 6, 2024 | — |
| 424B3 | Prospectus | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 27, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 27, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 10, 2024 | Jun 10, 2024 |
| 6-K | Current report (foreign issuer) | May 31, 2024 | May 31, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 424B5 | Prospectus supplement | May 8, 2024 | — |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 29, 2024 | Apr 29, 2024 |
| 6-K | Current report (foreign issuer) | Apr 22, 2024 | Apr 22, 2024 |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 11, 2024 | Apr 11, 2024 |
| EFFECT | Filing | Apr 3, 2024 | — |
| 424B3 | Prospectus | Apr 3, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 1, 2024 | — |
| POS AM | Filing | Apr 1, 2024 | — |
| 20-F | Annual report (foreign issuer) | Mar 19, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 19, 2024 | Mar 19, 2024 |
| 424B3 | Prospectus | Feb 28, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 28, 2024 | Feb 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| 424B3 | Prospectus | Nov 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 15, 2023 | Nov 15, 2023 |
| 424B3 | Prospectus | Aug 30, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 29, 2023 | Aug 29, 2023 |
| 424B3 | Prospectus | Aug 8, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Jul 12, 2023 | Jul 12, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 6, 2023 |
| 424B3 | Prospectus | Jun 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 13, 2023 | Jun 13, 2023 |
| 424B3 | Prospectus | Jun 7, 2023 | — |
| 424B4 | Prospectus | Jun 2, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 1, 2023 | Jun 1, 2023 |
| EFFECT | Filing | May 31, 2023 | — |
| 6-K | Current report (foreign issuer) | May 30, 2023 | May 30, 2023 |
| CORRESP | Letter to the SEC | May 30, 2023 | — |
| CORRESP | Letter to the SEC | May 30, 2023 | — |
| F-1 | Registration statement (foreign issuer) | May 30, 2023 | — |
| 424B3 | Prospectus | May 24, 2023 | — |
| 6-K | Current report (foreign issuer) | May 23, 2023 | May 22, 2023 |
| UPLOAD | Letter from the SEC | May 17, 2023 | — |
| S-8 | Employee stock plan registration | May 15, 2023 | — |
| DRS | Filing | May 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | May 4, 2023 | — |
| SC 13G | Ownership over 5% (passive) | May 2, 2023 | — |
| EFFECT | Filing | May 1, 2023 | — |
| 424B3 | Prospectus | May 1, 2023 | — |
| CORRESP | Letter to the SEC | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 20, 2023 | — |
| F-1/A | Filing | Apr 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Apr 14, 2023 | Apr 13, 2023 |
| UPLOAD | Letter from the SEC | Apr 13, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Apr 3, 2023 | — |
| 20-F | Annual report (foreign issuer) | Mar 28, 2023 | Dec 31, 2022 |
| SC 13G | Ownership over 5% (passive) | Mar 15, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Mar 13, 2023 | — |
| 20-F | Annual report (foreign issuer) | Mar 8, 2023 | Mar 2, 2023 |
| 6-K | Current report (foreign issuer) | Mar 3, 2023 | Mar 3, 2023 |
| CERT | Filing | Mar 2, 2023 | — |
| 8-A12B | Filing | Mar 1, 2023 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2023 | — |
| EFFECT | Filing | Feb 3, 2023 | — |
| 424B3 | Prospectus | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Feb 2, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| F-4/A | Filing | Feb 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| F-4/A | Filing | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2023 | — |
| CORRESP | Letter to the SEC | Jan 6, 2023 | — |
| F-4/A | Filing | Jan 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| F-4/A | Filing | Dec 12, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2022 | — |
| F-4 | Filing | Nov 7, 2022 | — |
Showing 138 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCS (Nasdaq), OCSAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1953530
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.